Tech Times on MSN

Oral pill for rare lung disease blocks 90% of damaging enzyme in phase 2, lands $475M deal

Alpha-1 antitrypsin deficiency treatment may soon include a daily pill: Mereo BioPharma and Sentynl Therapeutics signed a ...
The Chosun Ilbo on MSN

CRISPR anticancer tech targets cancer mutations, spares healthy cells

A domestic research team is developing an anticancer technology that attacks DNA mutations found only in cancer cells while ...

Fighting pathogens by watching how they read their own DNA: Q&A with structural biologist

Every living cell, from the simplest bacterium to a human neuron, relies on the same basic machinery to read, interpret, and use its DNA. This molecular machinery is so fundamental that life as we ...

Researchers help identify new Ebola variant and potential treatment

When the World Health Organization declared an Ebola outbreak in Uganda and the Democratic Republic of the Congo (DRC) a Public Health Emergency of International Concern in May, scientists around the ...

Vaxart outlines Phase IIb COVID-19 top line data in first half of 2027 backed by BARDA funding

"Revenue for the second quarter of 2026 was $27.2 million" and "Overall... a net loss of $13.5 million" (CFO Grasman) contrasted with Q1’s "Revenue for the first quarter was $39.2 million" and "a net ...
Diablo Magazine

2026 Best of the East Bay: Beauty, Health & Wellness

Franchesca Hashim and Alexandra Spunt, the East Bay founders of Good Weather Skin, teamed up when they couldn’t find face ...
Healthline

COVID Vaccine Study Previously Blocked By CDC Is Out — Here's What It Found

Share on Pinterest A study on COVID-19 vaccines that was previously blocked by the CDC’s acting director was published in a medical journal. luis velasco/Stocksy A COVID-19 vaccine efficacy study that ...
NBC News

Covid vaccine study the acting CDC director blocked is published in an outside journal

A study on Covid vaccines that the Centers for Disease Control and Prevention’s acting director blocked from publication came out Tuesday in a different journal. The findings show that Covid vaccines ...
The Hill

COVID-19 vaccine linked with lower risk of heart attack, stroke: Study

The COVID-19 vaccine lowered the risk of cardiovascular issues associated with the virus by around 40 percent, according to new research. The study, which was published in JAMA Internal Medicine on ...
STAT

Covid vaccination cut risk of adverse heart events, large study finds

Lauren writes about healthcare AI data interoperability, the science behind public health recommendations, and pharmaceutical advances in the rare disease space. Recent Covid vaccination appears to ...
Los Angeles Times

What COVID is teaching doctors about the relationship between viruses and cancer

This is read by an automated voice. Please report any issues or inconsistencies here. See more from the L.A. Times in Google Search. Set us as preferred The sheer scale of COVID’s spread has vastly ...
MedPage Today

COVID Shots Tied to Lower Risks of Heart Attack, Cardiac Death

COVID-19 vaccines were associated with a lower risk of major adverse cardiovascular events in a cohort study of veterans. The 2024-2025 vaccines also demonstrated effectiveness against ...